» Authors » R Dansey

R Dansey

Explore the profile of R Dansey including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 36
Citations 475
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bezwoda W, Dansey R
Leuk Lymphoma . 2016 Jul; 1(1):71-5. PMID: 27456411
Eleven patients with Hodgkin's disease relapsed from or refractory to conventional-dose chemotherapeutic regimens including MOPP and ABVD were treated by means of high-dose chemotherapy (either single agent melphalan or high-dose...
2.
Egerdie R, Saad F, Smith M, Tammela T, Heracek J, Sieber P, et al.
Prostate Cancer Prostatic Dis . 2012 May; 15(3):308-12. PMID: 22641239
Background: Denosumab, a fully human monoclonal antibody against RANK ligand, increased bone mineral density (BMD) and reduced fracture risk vs placebo in a phase 3 trial in men with prostate...
3.
Saad F, Brown J, Van Poznak C, Ibrahim T, Stemmer S, Stopeck A, et al.
Ann Oncol . 2011 Oct; 23(5):1341-1347. PMID: 21986094
Background: Osteonecrosis of the jaw (ONJ) has been reported in patients receiving bisphosphonates for metastatic bone disease. ONJ incidence, risk factors, and outcomes were evaluated in a combined analysis of...
4.
Peres E, Wood G, Poulik J, Baynes R, Sood S, Abidi M, et al.
Neuropediatrics . 2008 Nov; 39(3):151-6. PMID: 18991194
Pediatric patients with recurrent brain tumors have a poor prognosis and limited therapeutic options. We investigated the use of high-dose chemotherapy with adoptive immunotherapy for recurrent brain tumors. Three pediatric...
5.
Sloan A, Dansey R, Zamorano L, Barger G, Hamm C, Diaz F, et al.
Neurosurg Focus . 2006 Jul; 9(6):e9. PMID: 16817692
Object: This trial was designed to determine the ability of autologous whole-tumor cell vaccines to induce cell mediated immune responses in patients with recurrent malignant glioma, as well as to...
6.
Peres E, Savasan S, Klein J, Abidi M, Dansey R, Abella E
J Clin Microbiol . 2005 Jul; 43(7):3540-3. PMID: 16000501
Epstein-Barr virus (EBV)-associated lymphoproliferative disorder (EBV-LPD) following bone marrow transplantation can be fatal. The major risk factors for the development of EBV-LPD are ex vivo T-cell depletion or in vivo...
7.
Ibrahim R, Peres E, Dansey R, Abidi M, Abella E, Gumma M, et al.
Bone Marrow Transplant . 2005 Apr; 35(11):1071-7. PMID: 15821771
Few attempts have been made to examine the feasibility of safely administering low-molecular-weight-heparins (LMWHs) in the presence of concurrent thrombocytopenia. We retrospectively investigated the safety of low-dose LMWH in BMT...
8.
Shehadeh N, Dansey R, Seen S, Abella E
Bone Marrow Transplant . 2003 Nov; 32(11):1109-10. PMID: 14625586
No abstract available.
9.
Chandrasekar P, Abraham O, Klein J, Alangaden G, Chalasani G, Cassells L, et al.
Clin Infect Dis . 2001 Feb; 32(4):546-51. PMID: 11181116
Autologous peripheral blood progenitor cell (PBPC) transplantation is increasingly employed in the outpatient setting, yet data on early complications following PBPC transplantation are scant. We evaluated 105 women with high-risk...
10.
Baynes R, Hamm C, Dansey R, Klein J, Cassells L, Karanes C, et al.
Clin Chem . 2000 Aug; 46(8 Pt 2):1239-51. PMID: 10926918
This review focuses on certain of the principles involved in high-dose chemotherapy and radiation therapy along with autologous hematopoietic stem cell transplantation for the treatment of certain malignancies. In addition,...